Adage Capital Partners’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$333K Hold
66,666
﹤0.01% 893
2025
Q4
$460K Hold
66,666
﹤0.01% 864
2025
Q3
$543K Sell
66,666
-1
-0% -$13 ﹤0.01% 844
2025
Q2
$1.07M Hold
66,667
﹤0.01% 788
2025
Q1
$1.02M Hold
66,667
﹤0.01% 795
2024
Q4
$1.31M Sell
66,667
-15,658
-19% -$317K ﹤0.01% 809
2024
Q3
$1.71M Hold
82,325
﹤0.01% 789
2024
Q2
$1.63M Buy
82,325
+58,333
+243% +$1.03M ﹤0.01% 788
2024
Q1
$409K Hold
23,992
﹤0.01% 809
2023
Q4
$567K Sell
23,992
-10,000
-29% -$326K ﹤0.01% 779
2023
Q3
$1.77M Buy
33,992
+1,667
+5% +$100K ﹤0.01% 743
2023
Q2
$2.54M Buy
+32,325
New +$2.32M 0.01% 727

Other funds holding IMA

Adage Capital Partners's IMA Position: Q1 2026 in Review

Adage Capital Partners held its ImageneBio Inc (IMA) position steady in Q1 2026 at 66,666 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Adage Capital Partners first reported a position in IMA in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.54M in Q2 2023. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Adage Capital Partners held 66,666 shares of ImageneBio Inc worth $333K as of Q1 2026.
  • Adage Capital Partners left its ImageneBio Inc share count unchanged in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Adage Capital Partners's portfolio in Q1 2026, its #893 holding.
  • Adage Capital Partners first reported a position in ImageneBio Inc in Q2 2023 and has held it in 12 quarters since.
  • Adage Capital Partners's ImageneBio Inc position peaked at $2.54M in Q2 2023.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.